Texas Heart Institute gets $32M from patient, $1.14M for drug development

Houston-based Texas Heart Institute received a grant to develop a first-in-class drug for cardiovascular disease and received $32 million from a patient.

Advertisement

The National Heart, Lung and Blood Institute awarded the center $1.14 million to develop a better treatment for cardiovascular disease specifically for adverse events from atherosclerosis, according to an Aug. 22 center news release.

Texas Heart Institute also received $32 million from Frederick Weissman, MD, a neurologist from New York who was a patient of the center 40 years ago. The donation will be used to support cardiovascular research, Innovation Map reported Aug. 22.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Cardiology

Advertisement